EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in mass spectrometry for metabolomics: Strategies, challenges, and innovations in disease biomarker discovery

Nikhil Titkare, Sachin Chaturvedi iD, Sapan Borah, Nitish Sharma iD

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.6019 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Nikhil Titkare und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), An Institute of National Impo…. Hauptthemen laut MEDLINE: Metabolomics, Biomarkers, Mass Spectrometry. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 162 Literaturangaben. Gefördert von: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mass spectrometry (MS) plays a crucial role in metabolomics, especially in the discovery of disease biomarkers. This review outlines strategies for identifying metabolites, emphasizing precise and detailed use of MS techniques. It explores various methods for quantification, discusses challenges encountered, and examines recent breakthroughs in biomarker discovery. In the field of diagnostics, MS has revolutionized approaches by enabling a deeper understanding of tissue‐specific metabolic changes associated with disease. The reliability of results is ensured through robust experimental design and stringent system suitability criteria. In the past, data quality, standardization, and reproducibility were often overlooked despite their significant impact on MS‐based metabolomics. Progress in this field heavily depends on continuous training and education. The review also highlights the emergence of innovative MS technologies and methodologies. MS has the potential to transform our understanding of metabolic landscapes, which is crucial for disease biomarker discovery. This article serves as an invaluable resource for researchers in metabolomics, presenting fresh perspectives and advancements that propels the field forward.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomicsBiomarkersMass SpectrometryHumansAnimalsMetabolome

Stichwörter der Autor:innen

biomarkerdiseasemass spectrometrymetabolomics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), An Institute of National Importance, Government of India, Gandhinagar, Gujarat, India.
  • Department of Biotechnology, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), An Institute of National Importance, Government of India, Gandhinagar, Gujarat, India.

ORCID-Profile: Sachin Chaturvedi, Nitish Sharma

Förderung

  • Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers
  • Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India

Zitieren

APA

Titkare, N., Chaturvedi, S., Borah, S., & Sharma, N. (2024). Advances in mass spectrometry for metabolomics: Strategies, challenges, and innovations in disease biomarker discovery. Biomedical Chromatography. https://doi.org/10.1002/bmc.6019

Vancouver

Titkare N, Chaturvedi S, Borah S, Sharma N. Advances in mass spectrometry for metabolomics: Strategies, challenges, and innovations in disease biomarker discovery. Biomedical Chromatography. 2024. doi:10.1002/bmc.6019

BibTeX
@article{Titkare2024,
  author = {Titkare, Nikhil and Chaturvedi, Sachin and Borah, Sapan and Sharma, Nitish},
  title = {Advances in mass spectrometry for metabolomics: Strategies, challenges, and innovations in disease biomarker discovery},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.6019}
}
Kostenlos starten →